Between the multiple products moving from Phase 2 to 3 and looking to hit market soon, and the impending bull market, this BioTech Startup is poised to at least double by the beginning of February. There is going to be a lot more upside to CNTB in the coming year, and I believe we could see so much more than 2.00 CNTB
Chart PatternsTrend Analysis

Aussi sur:

Clause de non-responsabilité